---
title: "Akanda (AKAN.US) Soars 54% Intraday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284913032.md"
description: "Akanda（AKAN.US）现价 $75.370，当日 +53.94%，盘中快速拉升，市值 0.39 亿。公司主营医疗保健服务，本次大涨与医疗板块短线资金活跃有关。近期未见重大公告，股价波动或受板块整体情绪带动，市场关注短线交易机会。"
datetime: "2026-05-01T15:02:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284913032.md)
  - [en](https://longbridge.com/en/news/284913032.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284913032.md)
---

# Akanda (AKAN.US) Soars 54% Intraday

Akanda (AKAN.US) is trading at $75.370, up **+53.94%** intraday with a sharp surge. Market cap stands at $0.39 billion.

Akanda operates in healthcare services. The rapid rise reflects active short-term buying in the sector, with no notable company-specific announcements. Price movement appears driven by overall sector sentiment and short-term trading interest.

### Related Stocks

- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Akanda Corp. Delays 20-F Amid Strategic Shift](https://longbridge.com/en/news/284929092.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)